A very negative article for Qbiotic SH's. The ship has taken a...

A very negative article for Qbiotic SH's.
The ship has taken a new direction and a few key members have jumped overboard as they don't like the final destination they are heading for.

I don't see it all negative though. The realignment of human trialing of TT being scaled back to just concentrating on head and neck cancers. This will reduce costs and allow them to focus on attracting patients to get this trial completed.

One step at a time, and yes it has been a very slow and frustrating 10 years as a holder. It seems like the carrot of the company listing on the ASX in two years has been dangling in front of SH's for all my ownership.
Covid has thrown a spanner into the bio space for those businesses testing and trialling new drugs. We do need to give them some grace here.